J. Brimnes et al., Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease, EUR J IMMUN, 31(1), 2001, pp. 23-31
Scid mice transplanted with CD4(+) T cells from congenic donor mice develop
a chronic and lethal inflammatory bowel disease (IBD) 2-3 months post-tran
splantation. In the present study we have investigated the response of CD4(
+) T cells from sold mice with colitis against fecal extracts. Our results
show that in contrast to CD4(+) T cells from normal BALB/c mice, CD4(+) T c
ells from scid mice with colitis proliferate strongly in response to antige
n-presenting cells (APC) pulsed with fecal extracts. The IBD-associated T c
ells did not respond to either extracts from food antigens or fecal extract
s from germ-free mice, which indicates that they recognize bacterial antige
ns in the fecal extracts. CD4(+) T cells isolated from the colonic lamina p
ropria of scid mice 3 weeks post transplantation also responded vigorously
to fecal extracts, demonstrating that reactive CD4(+) T cells are present i
n the gut mucosa of transplanted scid mice prior to clinical manifestations
of IBD. CD4(+) T cells activated by fecal extracts produced high amounts o
f IL-2 and IFN-gamma, intermediate amounts of IL-4 and low amounts of IL-10
, consistent with a Th1 profile. The proliferative reactivity towards fecal
extracts was restricted by MHC class II molecules and dependent on antigen
processing, as the response could be blocked by anti-MHC class II antibodi
es or a short fixation of the APC. This study demonstrates that class II-re
stricted CD4(+) Th1 cells, which recognize enteric bacterial antigens, infi
ltrate the gut mucosa and spleen of transplanted sold mice prior to and dur
ing the course of colitis.